207
Views
0
CrossRef citations to date
0
Altmetric
Review

Variant influenza: connecting the missing dots

ORCID Icon, , , , , & ORCID Icon show all
Pages 1567-1585 | Received 17 Jun 2022, Accepted 01 Nov 2022, Published online: 18 Nov 2022

References

  • Chomel BB. Zoonoses. Schaechter M, editor. Encycl Microbiol. 2009. February. 17:820–829.
  • Chavda VP, Hossain MK, Beladiya J, et al. Nucleic acid vaccines for COVID-19: a paradigm shift in the vaccine development Arena. Biologics. 2021;1:337–356.
  • Chavda VP, Feehan J, Apostolopoulos V. A veterinary vaccine for SARS-CoV-2: the first COVID-19 vaccine for animals. Vaccines (Basel). 2021;9(6):631.
  • Rahman MT, Sobur MA, Islam MS, et al. Zoonotic diseases: etiology, Impact, and control. Microorg. 2020;8:1405.
  • Wang L-F, Crameri G. Emerging zoonotic viral diseases. Rev Sci Tech Int Off Epizoot. 2014;33:569–581.
  • Lindahl JF, Grace D. The consequences of human actions on risks for infectious diseases: a review. Infect Ecol Epidemiol. 2015;5:30048.
  • Rohr JR, Barrett CB, Civitello DJ, et al. Emerging human infectious diseases and the links to global food production. Nat Sustain. 2019;2(6):445–456.
  • Kumar S, Swain S, P GS, et al. Zoonotic diseases in India. Indian J Comm Med Off Publ. 2020;45:S1–S2.
  • Scavizzi F, Galligioni V, Vasina V, et al. Chapter 6 - Animal health management and hygiene. Dal Negro G, Sabbioni SBT-PH on the 3Rs in the C of the D 2010/63/EU, editor. United States: Academic Press;2022. 151–179.
  • Reed KDBT-RM in BS. Viral Zoonoses. United States: Elsevier; 2018.
  • Mirazimi A, Burt F, Papa A. Crimean-Congo hemorrhagic fever virus and nairoviruses of medical importance (Nairoviridae). Bamford DH, Zuckerman MBT-E. of V (Fourth E, editors. Oxford:Academic Press; 2021. 208–217.
  • Greger M. The human/animal interface: emergence and resurgence of zoonotic infectious diseases. Crit Rev Microbiol. 2007;33(4):243–299.
  • Bengis RG, Leighton FA, Fischer JR, et al. The role of wildlife in emerging and re-emerging zoonoses. Rev Sci Tech Int Off Epizoot. 2004;23:497–511.
  • WHO EMRO Zoonotic disease: emerging public health threats in the Region | RC61 | À propos de l’OMS.
  • Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature. 2009;459(7249):931–939.
  • Zhang Y, Zhang Q, Gao Y, et al. Key molecular factors in hemagglutinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virus. J Virol. 2012;86(18): 9666–9674. .
  • Dotis J, Roilides E. H1N1 influenza A infection. Hippokratia. 2009;13(3):135–138.
  • Swine flu (H1N1) - NHS.
  • Samui K. Steroid therapy in swine flu: beneficial or harmful. Apollo Med. 2018;15:2.
  • Damor R, Bhabhor H, Kosambiya JK, et al. Knowledge, attitude and practices regarding swine flu among OPD attendees of tertiary care hospital, Surat. IOSR J Dent Med Sci Ver III. 2015;14:2279–2861.
  • Rawal G, Yadav S, Kumar R. Swine Flu (H1N1 Influenza A): a concise review. IP Indian J Immunol Respir Med. 2017;2(2)29–32.
  • Dandagi GL, Byahatti SM. An insight into the swine-influenza A (H1N1) virus infection in humans. Lung India Off Organ Indian Chest Soc. 2011;28(1):34–38.
  • Patel KK, Patel AK, Mehta PM, et al. Clinical outcome of novel H1N1 (Swine Flu)-infected patients during 2009 pandemic at tertiary referral hospital in western India. J Glob Infect Dis. 2013;5(3):93–97.
  • Feehan J, Apostolopoulos V. Is COVID-19 the worst pandemic? Maturitas. 2021;149:56–58.
  • Rewar S, Mirdha D, Rewar P. Treatment and prevention of pandemic H1N1 influenza. Ann Glob Health. 2015;81(5):645–653.
  • Mostafa A, Abdelwhab EM, Mettenleiter TC, et al. Zoonotic Potential of Influenza A Viruses: a Comprehensive Overview. Viruses. 2018;10(9):497.
  • Met J. Nano.: structure of influenza viruses, connected with influenza life cycle.
  • Water Quality and Health Council. Chlorine bleach: helping to manage the flu risk. United States: Water Quality and Health Council 2009.
  • Te Velthuis AJW, Fodor E. Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis. Nat Rev Microbiol. 2016 July 11;14(8):479–493.
  • Vasin AV, Temkina OA, Egorov VV, et al. Molecular mechanisms enhancing the proteome of influenza A viruses: an overview of recently discovered proteins. Virus Res. 2014;185:53–63.
  • Reguera J, Cusack S, Kolakofsky D. Segmented negative strand RNA virus nucleoprotein structure. Curr Opin Virol. 2014;5:7–15.
  • Kosik I, Yewdell JW. Influenza Hemagglutinin and neuraminidase: yin−yang proteins coevolving to Thwart immunity. Viruses. 2019;11:346.
  • Noda T, Kawaoka Y. Structure of influenza virus ribonucleoprotein complexes and their packaging into virions. Rev Med Virol. 2010;20(6):380–391.
  • Gamblin SJ, Skehel JJ. Influenza Hemagglutinin and neuraminidase membrane glycoproteins *. J Biol Chem. 2010;285(37):28403–28409.
  • Noda T, Sagara H, Yen A, et al. Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature. 2006;439(7075):490–492.
  • Leiding T, Wang J, Martinsson J, et al. Proton and cation transport activity of the M2 proton channel from influenza A virus. Proc Natl Acad Sci U S A. 2010 August 16;107(35):15409–15414.
  • de Chassey B, Aublin-Gex A, Ruggieri A, et al. The interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replication. PLOS Pathog. 2013;9(7):e1003440.
  • Veit M, Thaa B. Association of influenza virus proteins with membrane rafts. Adv Virol. 2011;2011:370606.
  • Rossman JS, Lamb RA. Influenza virus assembly and budding. Virology. 2011;411(2):229.
  • Maines TR, Jayaraman A, Belser JA, et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science. 2009;325(5939): 484–487. .
  • Rust MJ, Lakadamyali M, Zhang F, et al. Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat Struct Mol Biol. 2004;11(6):567–573.
  • Kobasa D, Takada A, Shinya K, et al., Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature. 2004;431(7009): 703–707. .
  • Pinto LH, Lamb RA. The M2 proton channels of influenza A and B viruses. J Biol Chem. 2006;281(14):8997–9000.
  • Estrin MA, Hussein ITM, Puryear WB, et al. Host-directed combinatorial RNAi improves inhibition of diverse strains of influenza A virus in human respiratory epithelial cells. PLOS ONE. 2018;13(5):e0197246.
  • Ghosh A, Nandy A, Nandy P. Computational analysis and determination of a highly conserved surface exposed segment in H5N1 avian flu and H1N1 swine flu neuraminidase. BMC Struct Biol. 2010;10(1):1–10.
  • Lim BH, Mahmood TA. Influenza A H1N1 2009 (swine flu) and pregnancy. J Obstet Gynecol India. 2011;61(4):386–393.
  • Govt. of India. Pandemic Influenza A H1N1 Clinical management protocol and infection control guidelines directorate general of health. Directorate General of Health Services Ministry of Health and Family Welfare-Government of India. 2020.
  • Smith GJD, Vijaykrishna D, Bahl J, et al., Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nat. 2009;459(7250): 1122–1125. .
  • Schnitzler SU, Schnitzler P. An update on swine-origin influenza virus A/H1N1: a review. Virus Genes. 2009;39(3):279–292.
  • Ohwada K, Kitame F, Sugawara K, et al. Distribution of the antibody to influenza c virus in dogs and pigs in Yamagata prefecture, Japan. Microbiol Immunol. 1987;31(12):1173–1180.
  • Van Reeth K. Avian and swine influenza viruses: our current understanding of the zoonotic risk. Vet Res. 2007;38(2):243–260.
  • Das RR, Sami A, Lodha R, et al. Clinical profile and outcome of swine flu in Indian children. Indian Pediatr. 2011;48(5):373–378.
  • Steel J, Lowen AC. Influenza A virus reassortment. Curr Top Microbiol Immunol. 2014;385:377–401.
  • Pascua PNQ, Choi YK. Zoonotic infections with avian influenza A viruses and vaccine preparedness: a game of “mix and match. Clin Exp Vaccine Res. 2014;3(2):140–148.
  • Chauhan RP, Gordon ML. A systematic review analyzing the prevalence and circulation of influenza viruses in swine population worldwide. Pathogens . 2020;9(5):355.
  • Influenza vaccines and vaccination strategies in birds - ScienceDirect [Internet]. [cited 2022 Aug 23]. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0147957107000677.
  • Taubenberger JK, Reid AH, Lourens RM, et al. Characterization of the 1918 influenza virus polymerase genes. Nat. 2005;437(7060):889–893.
  • Rambaut A, Pybus OG, Nelson MI, et al. The genomic and epidemiological dynamics of human influenza A virus. Nat. 2008;453(7195):615–619.
  • Smith DJ, Lapedes AS, De Jong JC, et al. Mapping the antigenic and genetic evolution of influenza virus. Science. 2004;305(5682):371–376.
  • Taubenberger JK, Morens DM. Influenza: the mother of all pandemics - volume 12, number 1—January 2006 - emerging infectious diseases journal - CDC. Emerg Infect Dis. 1918;12(1):15–22.
  • Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis. 2006;12(1):15–22.
  • Morens DM, Taubenberger JK, Harvey HA, et al. The 1918 influenza pandemic: lessons for 2009 and the future. Crit Care Med. 2010;38(1):38.
  • Gaydos JC, Hodder RA, Top FH, et al. Swine influenza A at Fort Dix, New Jersey (January–February 1976). I. J Infect Dis. 1977;136:S356–S362.
  • Babazadeh A, Mohseni Afshar Z, Javanian M, et al. Influenza vaccination and Guillain–Barré syndrome: reality or fear. J Transl Intern Med. 2019;7(4):137–142.
  • Webby RJ, Swenson SL, Krauss SL, et al. Evolution of swine H3N2 influenza viruses in the United States. J Virol. 2000;74(18):8243–8251.
  • Kaufman J, Hassan M, Rytel M. Human infection with swine influenza virus– Wisconsin. MMWR Weekly. 1988;37(43):661–3.
  • Ma W, Kahn RE, Richt JA. The pig as a mixing vessel for influenza viruses: human and veterinary implications. J Mol Genet Med Int J Biomed Res. 2008;3:158–166.
  • Corti D, Misasi J, Mulangu S, et al. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science. 2016;351(6279):1339–1342.
  • Morens DM, Taubenberger JK, Fauci AS. The persistent legacy of the 1918 influenza virus. The New England Journal of Medicine. 2009;361(3):225–229.
  • Le Page M. Viruses from animals. New Sci. 2020;245(3271):10.
  • World Health Organization (WHO). World now at the start of 2009 influenza pandemic. Geneva, Switzerland; 2010.
  • Centers for Disease Control and Prevention (CDC). Update: influenza A(H3N2)v transmission and guidelines - five states. MMWR Morb Mortal Wkly Rep. 2012;(51–52):1741–4.
  • Summary of the 2014-2015 Influenza Season | CDC.
  • Neopane A. The Swine flu pandemic in Nepal. Kathmandu Univ Med J KUMJ. 2009;7(4):339–340.
  • Hasan F, Khan MO, Ali M. Swine flu: knowledge, attitude, and practices survey of medical and dental students of Karachi. Cureus. 2018.
  • Swine flu deaths in India: in 2017, India sees over 20-fold rise in swine flu cases | India news. Times of India. 2017 .
  • Sun H, Xiao Y, Liu J, et al. Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection. Proc Natl Acad Sci U S A. 2020;117(29):17204–17210.
  • Shaikh MY, Yasmin F, Ochani RK, et al. Influenza swine flu virus: a candidate for the next pandemic? J Glob Health. 2021;11:1–3.
  • Shaikh MY, Yasmin F, Ochani RK, et al. Influenza swine flu virus: a candidate for the next pandemic? J Glob Health. 2021;11:03011.
  • Update: novel Influenza A (H1N1) Virus Infections — worldwide, May 6, 2009.
  • Scalera NM, Mossad SB. The first pandemic of the 21st century: review of the 2009 pandemic variant influenza A (H1N1) virus. Postgrad Med. 2015;121:43–47. DOI:10.3810/pgm.2009.09.2051.
  • Pensaert M, Ottis K, Vandeputte J. Evidence for the natural transmission of influenza Avirus from wild ducts to swine and its potential importance for man. Bull World Health Organ.1981;59(1):75–8.
  • Brown IH. The epidemiology and evolution of influenza viruses in pigs. Vet Microbiol. 2000;74(1–2):29–46.
  • Wei C, Shan K-J, Wang W, et al. Evidence for a mouse origin of the SARS-CoV-2 Omicron variant. J Genet Genomics. 2021;48(12):1111–1121.
  • Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009;325:197–201.
  • Cohen J. Straight from the pig’s mouth: swine research with swine influenzas. Science. 2009;325(5937):140–141.
  • Vallat B. Flu: no sign so far that the human pandemic is spread by pigs. Nat. 2009;460(7256):683.
  • Jain S, Finelli L, Shaw MW, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605–2615.
  • Steel J, Lowen AC, Pena L, et al. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol. 2009;83(4):1742–1753.
  • van Doorn Hr, Yu H. Viral respiratory infections. Magill AJ, Hill DR, Solomon T, editors. London: W.B. Saunders; 2013. p. 269–274.
  • Saunders-Hastings PR, Krewski D. Reviewing the history of pandemic influenza: understanding patterns of emergence and transmission. Pathog Basel Switz. 2016;5(4):66.
  • Al Hajjar S, McIntosh K. The first influenza pandemic of the 21st century. Ann Saudi Med. 2010;30(1):1–10.
  • Cheng VCC, Kkw T, Tse H, et al. Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev. 2012;25(2):223–263.
  • Girard MP, Tam JS, Assossou OM, et al. The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine. 2010;28(31):4895–4902.
  • Cauchemez S, Donnelly CA, Reed C, et al., Household Transmission of 2009 Pandemic Influenza A (H1N1) Virus in the United States. N Engl J Med. 2009;361(27): 2619–2627. .
  • Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med. 2009;361(20):1935–1944.
  • Cao B, X-W L, Mao Y, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009;361(26):2507–2517.
  • da Costa Vg, Saivish MV, Santos DER, et al. Comparative epidemiology between the 2009 H1N1 influenza and COVID-19 pandemics. J Infect Public Health. 2020;13(12):1797–1804.
  • Types of Influenza Viruses | CDC.
  • Jilani TN, Jamil RT, Siddiqui AH. H1N1 Influenza.(StatPearls, Treasure Island (FL)). 2022.
  • Badar N, Salman M, Aamir UB, et al. Evolutionary analysis of influenza A(H1N1)pdm09 during the pandemic and post-pandemic period in Pakistan. J Infect Public Health. 2020;13(3):407–413.
  • Christman MC, Kedwaii A, Xu J, et al. Pandemic (H1N1) 2009 virus revisited: an evolutionary retrospective. Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis. 2011;11:803–811.
  • Short KR, Kedzierska K, van de Sandt CE. Back to the future: lessons learned from the 1918 influenza pandemic . Front Cell Infect Microbiol. 2018;8.
  • Detmer S, Gramer M, Goyal S, et al. Diagnostics and surveillance for swine influenza. Swine Influenza. 2013;370:85.
  • Ito T, Couceiro JNSS, Kelm S, et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol. 1998;72(9):7367–7373.
  • Quadrivalent Influenza Vaccine | CDC.
  • Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol. 2008;3(1):499–522.
  • Gangurde HH, Gulecha VS, Borkar VS, et al. Swine influenza A (H1N1 Virus): a pandemic disease. Syst Rev Pharm. 2011;2(2):110–124.
  • Swine flu virus turns endemic | swine influenza virus (SIV).
  • Opriessnig T, Mattei AA, Karuppannan AK, et al. Future perspectives on swine viral vaccines: where are we headed? Porc Health Manag. 2021 71; 7(1): 1–16.
  • Gramer MR, Lee JH, Choi YK, et al. Serologic and genetic characterization of north American H3N2 swine influenza A viruses. Can J Vet Res. 2007;71(3):201.
  • Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: a review of the literature. Clin Infect Dis. 2007;44(8):1084–1088.
  • Mackenzie D. Swine flu: the predictable pandemic? New Scientist. 2009.
  • Susan A, Asa M, Merck C. The merck veterinary manual. In: cooperation with Merial Ltd., 8th. 1998; Whitehouse Station N: J.: Merck & Co.
  • Louten J. Chapter 10 - influenza viruses. JBT-EHV L, editor. Boston: Academic Press; 2016. p. 171–191.
  • R-MB L, KM W, Wm M, et al. Influenza A virus field surveillance at a swine-human interface. mSphere. 2022;5:e00822–19.
  • Bresee JS, Fry AM, Sambhara S, et al. 31 - Inactivated Influenza Vaccines. Plotkin SA, Orenstein WA, Offit PA, et al. editors. United States: Elsevier; 2018. 456–488.e21.
  • Olsen CW, Brammer L, Easterday BC, et al. Serologic evidence of H1 swine influenza virus infection in swine farm residents and employees. Emerg Infect Dis. 2002;8(8):814–819.
  • Myers KP, Olsen CW, Setterquist SF, et al. Are Swine workers in the United States at increased risk of infection with zoonotic influenza virus? Clin Infect Dis. 2006;42(1):14–20.
  • Ramirez A, Capuano AW, Wellman DA, et al. Preventing zoonotic influenza virus infection. Emerg Infect Dis. 2006;12(6):997–1000.
  • Key facts about swine influenza (Swine Flu) in Pigs | CDC.
  • Vellozzi C, Burwen DR, Dobardzic A, et al. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine. 2009;27(15):2114–2120.
  • Key facts about human infections with variant viruses | CDC.
  • Collins AS. Preventing health care–associated Infections. Hughes RG, editor. Patient safety and quality: an evidence-based handbook for nurses, Rockville (MD):Agency for Healthcare Research and Quality (US); 2008. Apr. Chapter 41. Available from.
  • Powdrill TF, Nipp TL, Rinderknecht JL. One health approach to influenza: assessment of critical issues and options 1. Emerg Infect Dis. 2010;16(8):e1.
  • Mohammad NS, Nazli R, Zafar H, et al. Effects of lipid based multiple micronutrients supplement on the birth outcome of underweight pre-eclamptic women: a randomized clinical trial. Pak J Med Sci. 2022;38(1):219–226.
  • Webby RJ, Rossow K, Erickson G, et al. Multiple lineages of antigenically and genetically diverse influenza A virus co-circulate in the United States swine population. Virus Res. 2004;103(1–2):67–73.
  • Guarner J, Shieh WJ, Dawson J, et al. Immunohistochemical and in situ hybridization studies of influenza A virus infection in human lungs. Am J Clin Pathol. 2000;114(2):227–233.
  • Ciacci-Zanella JR, Vincent AL, Prickett JR, et al. Detection of anti-influenza A nucleoprotein antibodies in pigs using a commercial influenza epitope-blocking enzyme-linked immunosorbent assay developed for avian species. J Vet Diagn Investig Off Publ Am Assoc Vet Lab Diagn Inc. 2010;22(1):3–9.
  • Chander Y, Jindal N, Stallknecht DE, et al. Full length sequencing of all nine subtypes of the neuraminidase gene of influenza A viruses using subtype specific primer sets. J Virol Methods. 2010;165(1):116–120.
  • Spackman E, Senne DA, Myers TJ, et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol. 2002;40(9):3256–3260.
  • Low D. Reducing antibiotic use in influenza: challenges and rewards. Clin Microbiol Infect. 2008;14(4):298–306.
  • Mujariya R, Bodla R. A REVIEW ON STUDY OF SWINE FLU. 2014.
  • Morris DE, Cleary DW, Clarke SC. Secondary bacterial infections associated with influenza pandemics. Front Microbiol. 2017;8:1041.
  • Intervening Swine Flu Epidemic. 2016;
  • Heneghan CJ, Onakpoya I, Thompson M, et al. Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ. 2014;348(apr09 2):g2547–g2547.
  • Uhnoo I, Linde A, Pauksens K, et al. Treatment and prevention of influenza: Swedish recommendations. Scand J Infect Dis. 2003;35(1):3–11.
  • Mukherjee S, Sen S, Nakate PC, et al. Management of swine flu (H1N1 Flu) outbreak and its treatment guidelines. Community Acquir Infect. 2015;2(3):71.
  • Yadav S, Rawal G. Swine flu-have we learnt any lesson from the past ? Pamj. 2015;22(1):18.
  • Wang S-Q, Q-S D, Huang R-B, et al. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. Biochem Biophys Res Commun. 2009;386(3):432–436.
  • Jia R, Zhang J, Zhang J, et al. Discovery of novel boron-containing n-substituted oseltamivir derivatives as anti-influenza a virus agents for overcoming N1-H274Y oseltamivir-resistant. Molecules. 2022;27(19):6426.
  • Qin H-J, Li S, Zhu Y-B, et al. Oseltamivir modified bovine serum albumin inhibits neuraminidase activity and accumulates virion particles to disturb influenza virus replication. Carbohydr Res. 2022;520:108631.
  • Salomon R, Webster RG. The influenza virus enigma. Cell. 2009;136(3):402–410.
  • Chan M. Implementation of the international health regulations (2005) Annual report on the implementation of the International Health Regulations 2018.
  • CDC. H1N1 pandemic timeline | pandemic influenza (Flu) | CDC. 2009.
  • Centre for Disease Control and Prevention. Outbreak of swine-origin influenza A(H1N1) Virus Infection. Outbreak of swine-origin influenza A (H1N1) Virus InfectionMMWR Weekly —. 2009;58:1–3.
  • He W, Zhang W, Yan H, et al. Distribution and evolution of H1N1 influenza A viruses with adamantanes-resistant mutations worldwide from 1918 to 2019. J Med Virol. 2021;93(6):3473–3483.
  • Otte A, Marriott AC, Dreier C, et al. Evolution of 2009 H1N1 influenza viruses during the pandemic correlates with increased viral pathogenicity and transmissibility in the ferret model. Sci Rep. 2016 61; 6(1): 1–10.
  • Renaud C, Kuypers J, Englund JA. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1. J Clin Virol. 2011;52(2):70–78.
  • Fabian B, Commander MBA. FDA update on the H1N1 flu vaccine and antiviral medications.
  • Influenza A virus vaccine H1N1 - GlaxoSmithKline - AdisInsight.
  • WHO. cuts swine flu vaccine production estimate.
  • Transcript of virtual press conference with Gregory Hartl, Spokesperson for H1N1, and Dr Marie-Paule Kieny, WHO director of the initiative for vaccine research. World Health Organization. 2009.
  • Hineman M. World Health Organization. CSL H1N1 pandemic influenza vaccine NAME OF THE MEDICINE CSL H1N1 pandemic influenza vaccine. 2021.
  • U. S. Food and Drug Administration. Influenza A (H1N1) 2009 monovalent vaccine (ID biomedical corporation of Quebec) | 2009.
  • U. S. Food and Drug Administration. Influenza A (H1N1) 2009 monovalent vaccine (Novartis vaccines and diagnostics limited) | 2009.
  • Clinical Trials Arena. Influenza A (H1N1) Monovalent Vaccine by Sanofi Pasteur. 2009.
  • U. S. Food and Drug Administration. Influenza A (H1N1) 2009 Monovalent Vaccine (MedImmune LLC) | 2009.
  • Carlsen B, Glenton C. The swine flu vaccine, public attitudes, and researcher interpretations: a systematic review of qualitative research. BMC Health Serv Res. 2016;16(1).
  • Wu J, Xu F, Lu L, et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med. 2010;363(25):2416–2423.
  • Clinical Trials Arena. Safety of Influenza A (H1N1) 2009 monovalent vaccines — United States. 2009.
  • Der Vliet D V, Pepin S, Lambert M, et al. Similar immunogenicity of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccine. Human Vaccines. 2010;6(10):823–828.
  • Simpson CR, Ritchie LD, Robertson C, et al. Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study. Lancet Infect Dis. 2012;12(9):696–702.
  • Valenciano M, Kissling E, Cohen J-M, et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009–2010: results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study. PLOS Med. 2011;8(1):e1000388.
  • National Institutes of Health. H1N1 vaccine safe and induces robust immune response in people with asthma. 2009.
  • Busse WW, Peters SP, Fenton MJ, et al. Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine. J Allergy Clin Immunol. 2011;127(1):130–137.e3.
  • Liang X-F, Li L, Liu D-W, et al. Safety of Influenza A (H1N1) vaccine in postmarketing surveillance in China. N Engl J Med. 2011;364(7):638–647.
  • World Health Organization. Influenza pandemic preparedness plan : the role of WHO and guidelines for national and regional planning. 1999.
  • Michaelis M, Doerr HW, Cinatl J. Novel swine-origin influenza A virus in humans: another pandemic knocking at the door. Med Microbiol Immunol. 2009;198(3):175–183.
  • Barker CIS, Snape MD. Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action. Lancet Infect Dis. 2014;14(3):227–238.
  • McCullers JA, Van De Velde LA, Allison KJ, et al. Recipients of vaccine against the 1976 “swine flu” have enhanced neutralization responses to the 2009 novel H1N1 influenza virus. Clin Infect Dis. 2010;50(11):1487–1492.
  • Lansbury LE, Smith S, Beyer W, et al. Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: a systematic review and meta-analysis. Vaccine. 2017;35(16):1996–2006.
  • Malik JA, Ahmed S, Mir A, et al. The SARS-CoV-2 mutations versus vaccine effectiveness: new opportunities to new challenges. J Infect Public Health. 2022;15(2):228–240.
  • Swine flu (Influenza A H1N1) follow on vaccine study - no study results posted - clinicalTrials.gov.
  • Lambe T, Spencer AJ, Mullarkey CE, et al. T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine. Pediatr Infect Dis J. 2012;31(6):e86–e91.
  • Nicola M, Alsafi Z, Sohrabi C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg Lond Engl. 2020 [April 17];78:185–193.
  • Hilyard KM, Freimuth VS, Musa D, et al. The vagaries of public support for government actions in case of a pandemic. Health Affairs Project Hope. 2010;29(12):2294–2301.
  • Howden KJ, Brockhoff EJ, Caya FD, et al. An investigation into human pandemic influenza virus (H1N1) 2009 on an Alberta swine farm. Can Vet J Rev. 2009;50:1153–1161.
  • Hobday RA, Cason JW. The open-air treatment of pandemic influenza. Am J Public Health. 2009 May 21;99(Suppl 2):S236–S242.
  • Franco-Paredes C, Hernandez-Ramos I, Del Rio C, et al. H1N1 influenza pandemics: comparing the events of 2009 in Mexico with those of 1976 and 1918-1919. Arch Med Res. 2009;40(8):669–672.
  • Peiris JSM, de Jong MD, Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev. 2007;20(2):243–267.
  • James SH, Whitley RJ. 172 - influenza viruses. Cohen J, Powderly WG, SMBT-ID O. (Fourth E. editors. United States: Elsevier; 2017. 1465–1471.e1.
  • Institute of Medicine (US) Forum on Microbial Threats. Pandemic Influenza Vaccines: Obstacles and Opportunities, National Academies of Sciences, Engineering, and Medicine. In: Knobler SL, Mack A, Mahmoud A, et al. editors. The threat of pandemic influenza: are we ready? Workshop summary. Washington (DC):National Academies Press (US);2005:177–183. https://doi.org/10.17226/11150
  • Wong -S-S, Webby RJ. Traditional and new influenza vaccines. Clin Microbiol Rev. 2013;26(3):476–492.
  • Wang Q, Zhang T, Zhu H, et al. Characteristics of and public health emergency responses to COVID-19 and H1N1 Outbreaks: a case-comparison study. Int J Environ Res Public Health. 2020;17(12):4409.
  • World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 20222023 northern hemisphere influenza season [Internet]. 2022 [cited 2022 May 25]. p. 1–11. Available from: https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2022-2023-northern-hemisphere-influenza-season.
  • Jilani TN, Jamil RT, Siddiqui AH. H1N1 Influenza. [ Updated 2022 Feb 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. . Available from: https://www.ncbi.nlm.nih.gov/books/NBK513241/.
  • Lee BY, Bailey RR, Wiringa AE, et al. Antiviral medications for pregnant women for pandemic and seasonal influenza: an economic computer model. Obstet Gynecol. 2009;114(5):971–980.
  • Hannoun C. The evolving history of influenza viruses and influenza vaccines. Expert Rev Vaccines. 2013;12(9):1085–1094.
  • Huang Y, França MS, Allen JD, et al. Next Generation of computationally optimized broadly reactive ha vaccines elicited cross-reactive immune responses and provided protection against H1N1 virus infection. Vaccines (Basel). 2021;9(7):793.
  • Chavda VP, Apostolopoulos V. Global impact of delta plus variant and vaccination. Expert Rev Vaccines. 2022;21(5):597–600. null-null.
  • Chavda VP, Kapadia C, Soni S, et al. A global picture: therapeutic perspectives for COVID-19. Immunotherapy. 2022;14(5):351–371.
  • Basu D, Chavda VP, Mehta AA. Therapeutics for COVID-19 and post COVID-19 complications: an update. Curr Res Pharmacol Drug Discov. 2022;3:100086.
  • Chavda VP, Pandya R, Apostolopoulos V. DNA vaccines for SARS-CoV-2: towards third generation vaccination era. Expert Rev Vaccines. 2021;20(12):1549–1560.
  • Chavda VP, Vora LK, Vihol DR. COVAX-19Ⓡ Vaccine: completely blocks virus transmission to non-immune individuals. Clin Complement Med Pharmacol. 2021;1(1):100004.
  • Shah D, Vivek Chavda HT. Nasal medication conveyance framework: an approach for brain delivery from essential to cutting edge. Res Rev J Med. 2016;6:14–27.
  • Chavda VP, Kumar A, Banerjee R, et al. Ayurvedic and other herbal remedies for dengue: an update. Clin Complement Med Pharmacol. 2022;2(3):100024.
  • Chavda VP, Patel AB, Vihol D, et al. Herbal remedies, nutraceuticals, and dietary supplements for COVID-19 management: an update. Clin Complement Med Pharmacol. 2022;2(1):100021.
  • Chavda VP, Apostolopoulos V. Is booster dose strategy sufficient for omicron variant of SARS-CoV-2? Vaccines (Basel). 2022;10(3):367.
  • Chavda VP, Patel AB, Vaghasiya DD. SARS-CoV-2 variants and vulnerability at the global level. J Med Virol. 2022;94(7):2986–3005. n/a.
  • Chavda VP, Bezbaruah R, Athalye M, et al. Replicating Viral vector-based vaccines for COVID-19: potential avenue in vaccination arena. Viruses. 2022;14(4):759.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.